Suppl. Figure 1 from A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast CancerX. Cynthia, Matthew J. Ellis, César Sánchez et al.|Unknown|2023Cited by 0
Suppl. Figure 1 from A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast CancerX. Cynthia, Matthew J. Ellis, Michael Naughton et al.|Unknown|2023Cited by 0